Flu season visitor restriction – age 16 or older (Restricción de visitantes durante la Temporada de Influenza (Flu) – Mayores de 16 años.)

Flu Season Visitor Restriction

Visitors temporarily restricted to age 16 or older

As a safety first organization, ChristianaCare is implementing a temporary visitation age restriction starting Tuesday, Jan. 21. This temporary restriction protects patients, their loved ones and health care workers during this time of extremely high number of influenza cases and other respiratory illnesses circulating in our community.

The new restrictions limit visitors to patients in Christiana and Wilmington hospitals to persons age 16 or older. Children and teens younger than 16 years are most likely to get the flu and remain contagious longer than adults. This restriction does not apply to outpatient and ambulatory services.

Thank you for your understanding and cooperation.

For more information about the Flu visit our Health Library.

Restricción de visitantes durante la Temporada de Influenza (Flu)

Temporalmente solo se permiten los visitantes mayores de 16 años.

Como una organización que promueve la seguridad ante todo, ChristianaCare está implementando una restricción temporal en la edad de visitantes a partir del viernes 21 de enero. Esta restricción temporal protege a los pacientes, a sus seres queridos y al personal de cuidados de salud durante esta época con un número extremadamente alto de casos de influenza y de otras enfermedades respiratorias que circulan en nuestra comunidad.

Las nuevas restricciones, en los hospitales Christiana y Wilmington, sólo permiten visitas a pacientes de personas mayores de 16 años. Los niños y adolescentes menores de 16 años son más propensos a contraer el flu y son contagiosos por más tiempo que los adultos. Esta restricción no aplica a las áreas de servicios ambulatorios.

Gracias por su comprensión y cooperación.

Para más información sobre la gripe, visite nuestra Biblioteca de Salud.

Cancer Research at the
Helen F. Graham Cancer Center
& Research Institute

About Cancer Clinical Trials

When you join a cancer research study, commonly referred to as a clinical trial, you benefit from some of the latest techniques and therapeutic advances in the fight against cancer. At the same time, you are helping to improve our knowledge in ways that will help people with cancer to live longer and enjoy a better quality of life. Other benefits of clinical trials include:

  • The very latest medicines available to treat your cancer.
  • Frequent and thorough medical exams.
  • The latest information to help you better understand your condition.
  • The guidance you need to improve your health.
  • Support and counseling from doctors and nurses on the hospital’s research staff.

There are four types of cancer clinical trials:

  • Prevention trials test new drugs or techniques designed to prevent the development of cancer in people at risk.
  • Control trials test treatments for the symptoms and side effects caused by cancer and examine quality-of-life issues.
  • CCDR trials are focused on patient, provider and organizational level influences on cancer outcomes.
  • Treatment trials test the effectiveness of new cancer therapies and drugs.

Along with our partners at the Center for Translational Cancer Research and the University of Delaware Department of Biological Sciences, ChristianaCare’s Cancer Research Program conducts all three types of clinical trials. If you are a patient at the Helen F. Graham Cancer Center & Research Institute, your cancer care-management team will discuss clinical trials with you. But you may also contact the Cancer Research Program directly to learn more about clinical trials and find out which ones you may be eligible for. For immediate, real-time access to all National Cancer Institute approved cancer trials that are open at ChristianaCare, visit

Researching the cancer-fighting drugs of tomorrow

Treatment trials that test new cancer drugs proceed through several stages before successful new drugs can be made available to the general population. These drugs are first tested in laboratory and animal studies. Medicines that proceed to be tested in people must follow rigid guidelines set by the U.S. Food and Drug Administration.

Research studies to test new drugs in people are categorized in four phases:

  • Phase I clinical trials involve a small group of volunteers. They are designed to test a drug’s safety and to determine how it works in the human body.
  • Phase II studies test the effectiveness of the drug on a few hundred, closely monitored volunteer patients who have the disease the drug is designed to treat.
  • Phase III trials involve several thousand volunteer patients who are closely monitored in clinics and hospitals to confirm the effectiveness and adverse effects of the drug in treating their illness compared to standard therapy.
  • Phase IV trials are sometimes required by the FDA to evaluate any long-term effects of a drug or treatment.

Cancer Research Program
Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Newark, DE 19713 directions
For more information, call 302-623-4450 or e-mail us.